Dr. Amir Abdul-Jabbar, MD

Dr. Abdul-Jabbar practices at Swedish Issaquah Campus in Issaquah, Washington, part of Providence Health & Services.

Dr. Abdul-Jabbar's NPI, 1801155767, was assigned on May 14, 2012. Dr. Abdul-Jabbar graduated from University of California, San Francisco School of Medicine in 2012. Dr. Abdul-Jabbar holds Washington license MD60744420.

Dr. Abdul-Jabbar's primary practice is Swedish Issaquah Campus, at 751 NE Blakely Dr, Issaquah, WA 98029 in King County. The practice phone is (425) 313-4000.

Dr. Abdul-Jabbar's primary practice is Swedish Issaquah Campus in Issaquah, Washington, part of Providence Health & Services. Dr. Abdul-Jabbar is also affiliated with Swedish Cherry Hill Campus. The medical group on file is Swedish Health Services. Dmand AI also links Dr. Abdul-Jabbar to 3 more hospitals, 2 group practices and clinics, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdul-Jabbar practices, 8 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Abdul-Jabbar's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Abdul-Jabbar is licensed in Washington.

CMS data shows 357 Medicare services from Dr. Abdul-Jabbar across 6 procedure codes in 2024, for 223 Medicare patients. Medicare paid $57,103 for them.

CMS counts 223 Medicare patients who saw Dr. Abdul-Jabbar in 2024. The largest group is 65 to 74, with 113 patients. 75% of them have arthritis, and 72% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abdul-Jabbar's median patient age at 70, with 48% women.

In 2024, Dr. Abdul-Jabbar wrote 76 Medicare Part D claims for 38 patients. 100% of them were for generic drugs. CMS names the drug for 50 of them, across 3 drugs with 11 or more claims each, at $343 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Abdul-Jabbar for performance year 2024, reported as part of a group. Dr. Abdul-Jabbar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdul-Jabbar as offering telehealth. CMS counts 121 procedures of spinal fusion by Dr. Abdul-Jabbar, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 35 papers to Dr. Abdul-Jabbar, published from 2017 to 2025. 2025 was the busiest year, with 10. The most frequent topics are Spinal Fusion, Postoperative Complications and Bone Screws. Dr. Abdul-Jabbar has published most often in World Neurosurg. Dr. Abdul-Jabbar's most frequent co-authors are Rod J. Oskouian, MD, Jens R. Chapman, MD and Donald David Davis, MD.

CMS Open Payments shows 236 general payments to Dr. Abdul-Jabbar from 29 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 27% of the total. Globus Medical, Inc. paid the most, $30,578.

Dr. Abdul-Jabbar graduated from University of California, San Francisco School of Medicine in 2012.